Clinical trials
Kidney Transplant clinical trials
Below are recruiting kidney transplant clinical trials, each written for real people, not researchers. We’re tracking 244 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05285878Enrolling by invitationPhase 2
Fingolimod to protect kidney function after kidney transplant
This trial tests whether fingolimod can reduce kidney scarring and preserve kidney function after a new kidney transplant. It focuses on people who are in the early period after transplant who may be at risk for scarring in the kidney.
Houston, TexasAges 18–65 - NCT05224583Enrolling by invitation
Study BK virus after combined liver and kidney transplant
This study looks at how often BK virus shows up in people after a combined liver-kidney transplant. It may help the transplant team better predict and manage this virus after surgery.
Dallas, TexasAges 18–100 - NCT04182607Recruiting
Looking at outcomes after kidney donation surgery
This review looks at results for kidney donors and recipients who had kidney transplant surgery done either by hand-assisted or robotic methods. It aims to understand how these surgical approaches affect donor and recipient outcomes.
Dallas, TexasAges 18 years+ - NCT04783441Recruiting
Continuous glucose sensor study after kidney transplant
This study checks whether using a continuous glucose monitor (a sensor that tracks sugar throughout the day) is helpful and practical for people with a recent kidney transplant and type 2 diabetes on insulin. You may need to wear the sensor continuously and still do finger-stick glucose checks for safety.
Sacramento, CaliforniaAges 18 years+ - NCT05015231Recruiting
MRI study after fistula closure in kidney transplant patients
This trial uses special MRI scans to see how blood flow in the transplanted kidney changes after your fistula is surgically closed. It may help doctors better understand what healthy recovery looks like after the procedure.
ZurichAges 18 years+ - NCT05938712RecruitingPhase 2
Kidney transplant trial using two diabetes medicines safely
This Phase 2 trial tests whether combining two diabetes medicines—an SGLT2 tablet and a GLP-1 shot (semaglutide)—can improve kidney outcomes and safety in people with a kidney transplant. It may help some recipients, but it also carefully checks for infection risk, diabetes complications, and pregnancy plans.
Toronto, OntarioAges 18 years+ - NCT05968833Recruiting
Parent peer support for kids after kidney transplant
This program pairs parents with other parents who have been through a pediatric kidney transplant. It may help you cope and adjust by sharing experiences and support through WhatsApp.
Toronto, OntarioAges 18–75 - NCT06089473Recruiting
Home Exercise Program for Frail Kidney Transplant Candidates
This study tests whether a 12-week home exercise program (supervised by video calls) can help people who are frail feel stronger and healthier before a kidney transplant. You'll do exercises at home and connect with a trainer online.
Montreal, QuebecAges 18 years+ - NCT06100965Recruiting
Lower dose alemtuzumab for kidney transplant rejection
This trial tests a reduced dose of alemtuzumab, a medicine that calms the immune system, for people whose kidney transplant is being rejected and standard treatments haven't worked or aren't safe.
Rotterdam, South HollandAges 18 years+ - NCT06147076Recruiting
Social support counseling for kidney transplant candidates
This study tests a counseling program that helps kidney transplant candidates and their family or friends work together to improve social support during the transplant process.
Minneapolis, MinnesotaAges 18 years+ - NCT06314230Recruiting
Genomics of chronic kidney transplant failure study
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
Westmead, New South WalesAges 18–75 - NCT06337942Recruiting
Bladder or kidney-bladder transplant from a deceased donor
This trial offers a first-in-human transplant of a bladder or a kidney combined with a bladder from a deceased donor. It is for people with severe bladder problems or bladder cancer who already need a new bladder or are on immune-suppressing medicines for a prior organ transplant.
Los Angeles, CaliforniaAges 18–70 - NCT06655857Recruiting
Kidney transplant empowerment program
This study tests a program to help people with advanced kidney disease learn about and prepare for a kidney transplant. It is for patients who get kidney care at certain hospitals in New York and speak English or Spanish.
New York, New YorkAges 18–75 - NCT06675903Recruiting
Continuous Glucose Monitoring After Kidney Transplant
This study tests a small sensor called a continuous glucose monitor (CGM) that tracks your blood sugar after kidney transplant. It helps doctors see how your body handles sugar during recovery.
Copenhagen, DKAges 18 years+ - NCT06751992RecruitingPhase 4
Thinking and memory with extended-release tacrolimus in kidney transplant
This study tests if switching to an extended-release form of your anti-rejection medication (tacrolimus) helps protect memory and thinking skills. It is for older adults who have had a kidney transplant at least one year ago.
Boston, MassachusettsAges 65 years+ - NCT06759961Recruiting
Outcomes after kidney transplant for a blood vessel condition
This study looks at outcomes after kidney transplant for a rare blood vessel condition called thrombotic microangiopathy. It aims to learn more about how patients do after transplant at a specific center in Bologna, Italy.
Bologna, BOAges 18 years+ - NCT06777719RecruitingPhase 1
A study of immune cells to prevent kidney rejection
This trial tests if giving you back specially grown immune cells (called Tregs) made from your own blood can help your body accept a new kidney from a living donor with less rejection. It is for people who are ready for a first kidney transplant.
NantesAges 18–99 - NCT06806670Recruiting
Diet and exercise study for kidney transplant patients
This study tests whether a structured diet and exercise program can lower heart disease risk in kidney transplant recipients. If you've had a stable transplant for at least 6 months and up to 10 years, you may be able to join.
Bologna, BOAges 30–69 - NCT06833463Recruiting
Tacrolimus and diabetes risk in kidney transplant patients
This study looks at how the anti-rejection drug tacrolimus (specifically Envarsus) affects blood sugar and risk of diabetes in kidney transplant patients. It aims to find out which patients might be more likely to develop glucose problems so doctors can adjust treatment early.
GdanskAges 18 years+ - NCT07060716Recruiting
Blood test to monitor kidney transplant health
This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.
Los Angeles, CaliforniaAges 18 years+ - NCT07096453RecruitingPhase 1/Phase 2
CMV prevention in kidney transplant patients switching to belatacept
This trial tests whether an experimental drug (CMVIG) can prevent CMV infection in kidney transplant patients who are switching to or already on belatacept, a newer immunosuppressant. It may help protect those at higher risk for CMV.
Minneapolis, MinnesotaAges 18–70 - NCT07266467RecruitingPhase 4
Preventing CMV After First Kidney Transplant
This trial tests a new medicine, Leymovir, against a standard one, Valganciclovir, to prevent a common virus infection (CMV) after a first kidney transplant. It may help you avoid CMV-related illness.
Xi'an, ShaanxiAges 18 years+ - NCT03943238RecruitingPhase 1
Kidney transplant with immune therapy to prevent rejection
This trial tests a combination of low-dose radiation, chemotherapy, and donor immune cells to help your body accept a living donor kidney without long-term anti-rejection drugs.
Palo Alto, CaliforniaAges 18–65 - NCT07370727Recruiting
Weight training for kidney transplant patients
This trial studies whether a personalized weight training program helps kidney transplant recipients improve their strength and health. It is for people who are at least one year post-transplant and have stable kidney function.
Bogotá, Bogota D.C.Ages 18–50
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for kidney transplant?
- Yes. Clin2 currently lists 244 recruiting kidney transplant studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a kidney transplant trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a kidney transplant trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.